Initial experience with technetium-99m HM-PAO brain SPECT. 1987

I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
Abteilung für Neuronuklearmedizin der Neurologischen Universitätsklinik Wien, Vienna, Austria.

Technetium-99m hexamethylpropyleneamineoxime ([99mTc]HM-PAO) brain single photon emission computed tomography (SPECT) was performed with a dual head rotating scintillation camera. Normal tracer distribution and side/side differences of counting rates were obtained in 11 healthy volunteers. Almost stable gray/white matter ratios were found (1.97-2.1) in one normal subject during 2 hr after tracer administration. Eighty-three investigated patients had the following diagnoses (in parentheses is percent of positive findings in each group): cerebral vascular disease 18 (94.4%), epilepsy 23 (82.6%), extrapyramidal disorders 8 (100%), dementia 12 (100%), headache 11 (63.6%), psychiatric disorders 11 (27.3%). In addition, SPECT was performed in 28 male volunteers during motor or visual imagery tasks and a significant increase (p = 0.035) of relative tracer deposition was observed in the left inferior occipital region during visual imagery when compared with motor imagery. The results indicate that [99mTc]HM-PAO SPECT is valuable for demonstrating pathologic and physiologic changes of the brain.

UI MeSH Term Description Entries
D007092 Imagination A new pattern of perceptual or ideational material derived from past experience. Imaginations
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders

Related Publications

I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
November 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
January 1985, The Journal of nuclear medicine and allied sciences,
I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
February 1988, Clinical nuclear medicine,
I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
January 1989, Yonsei medical journal,
I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
November 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
June 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
January 1988, European journal of nuclear medicine,
I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
May 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
June 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Podreka, and E Suess, and G Goldenberg, and M Steiner, and T Brücke, and C Müller, and W Lang, and R D Neirinckx, and L Deecke
November 1989, Clinical nuclear medicine,
Copied contents to your clipboard!